A double blind multicentre study of OM-8980 and auranofin in rheumatoid arthritis.
The therapeutic efficacy of the immunomodulator OM-8980 in rheumatoid arthritis was compared with that of auranofin, an oral gold salt, in a double blind, randomised multicentre study lasting six months. Seventy patients were treated with auranofin and 75 with OM-8980. The patients of both groups im...
Na minha lista:
| Publicado no: | Ann Rheum Dis |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
1988
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC1003574/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3041924/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/ard.47.7.582 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|